Re: Give them some credit
2
jwills1213 wrote:
Just a guess, but perhaps they spent the majority of their R&D resources on the E-M1X.
To me, it's a bit unfortunate that the E-M1X, a camera which is their flagship and sort of serves as a demonstrator of their best technologies (the fruits of all that R&D) doesn't appear to have any appreciable improvement to the sensor. Not sure if there were any gains to be had here, maybe going to BSI ?
Well, the main thrust with E-M1X was in the features/ergonomics/software department. And there's nothing missing there. There's nothing like it on the market right now.
As for the sensor, seeing how there's still no sensor as fast as the one in E-M1 II and E-M1X, I'm not really sure there was anything to chase there. I mean, would you be happy if they used a new BSI sensor with 1/3 stop better DxO numbers (best case), but no handheld High Res, slower tripod High Res (PEN-F level), worse AF, noticeable EVF lag, slower EVF refresh, crippled ProCapture mode, worse rolling shutter and so on? Would that make any sense?
If they didn't use a sensor that's as fast as the one in E-M1 II, they would not have been able to make a camera with all the E-M1 II features and then some.
It's actually E-M5 Mark III where there's an opportunity to use a new sensor. Because nobody expects it to be an action shooting camera. So a gimped ProCapture mode, slower burst rates and slower EVF refresh with a bit more lag will be fine by most. In exchange, they could use a higher resolution EVF panel, for example.
With camera sales on the decline, I can understand why they would want to put out a camera with high profit margins like the E-M1X. Presumably to help recoup the R&D cost, pieces of the E-M1X tech will be rolled into products lower in the line up so they can get a leg up in their respective segments.
I think the R&D on AI subject recognition probably had great value for Olympus. This kind of technology has great potential in medical imaging uses and that's actually where Olympus has most of its eggs. It's probably one of those few cases where the technology developed for the camera can have a huge impact on their medical products and can actually bring in a lot of money in the long run. At least if they did it right.
I would guess that the E-M5.3 is going to have the updated sensor either from the PEN-F or the E-M1.2 (probably without the PDAF as that appears to be the niche of the M1 line),
PDAF or not, in 2019 Olympus simply cannot release a camera whose AF performs worse than E-M1 Mark II. It's not an option. And since Olympus CDAF is not as good as Panasonic's, I would expect they will have to rely on PDAF crutch.
the improved IBIS, maybe hand held high-res, and maybe limited implementation of the AI tracking from the E-M1X.
Yeah, it's going to be interesting to see if Olympus can do the AI stuff on something lesser than two TruPic VIII processors. If not, then I think they are in trouble. Panasonic and Sony managed to implement it without a need for an extra processor and additional heatsinks inside the camera body.
Alas, for E-M5 III, I would expect they could drop trains, planes and cars in favor of people/faces.
Maybe an upgraded EVF?
That's an easy upgrade.
I would expect the price to be about $1300.
Me too.
It's possible that longer term, the company strategy is to invest in software-based improvements to IQ to get around the sensor size limitation.
Rightly so. Handheld High Res mode already brings image quality to FF level, much like its tripod variant, but with less limitations. They really should implement raw HDR in a similar manner. They clearly have the tech.
The AI assisted focusing in the E-M1X could be the first step.
How about AI assisted bokeh?